Lumora MD review

The missing number is the total cost

Lumora MD did not publish medication prices on the homepage, how-it-works page or dedicated semaglutide and tirzepatide pages checked in October 2026. That limits a useful comparison: you can see the treatment categories, but not what your prescribed plan would cost. I would ask for a written quote before deciding rather than assume a price from another provider applies here.

The product pages add an important detail: baseline metabolic labs are required. Lumora says visit, medication, lab and follow-up costs are shown before you commit. Those categories are not publicly quantified in the recorded check, so this is not an established all-inclusive offer. Ask which charges are required, when they fall due, and what the next refill would cost. The absence of a public price does not establish that sharing a complete medical history is the only way to request a quote.

What the public information does establish

Lumora has dedicated pages naming semaglutide and tirzepatide. That is more specific than its general description of GLP-1 and dual-incretin care, but it does not settle the exact product, formulation, prescribed dose or dispensing pharmacy. I would confirm those details individually. A treatment category alone does not tell you whether the prescription would be a branded or compounded product, or establish approval of a particular formulation.

• Lumora claims LegitScript certification; that claim is not a substitute for checking who prescribes and dispenses your particular treatment.
• The site says it serves all fifty states. Confirm access for your state and chosen treatment before enrolling.
• It publishes (833) 332-2583, with hours of Monday to Friday, 8am to 8pm Eastern. That provides a public contact route for questions about the quote and care arrangements.
• It describes provider review as typically within 24 hours. That is a stated review timeframe, not a guarantee of a prescription or delivery within a day.

Questions about the companies and other therapies

The recorded policy review found Blue Skies MD LLC in the privacy policy and Blue Skies LLC in the terms. I would ask which entity handles the agreement, clinical care and billing rather than guess whether the difference is a typo. The reviewed pages did not identify a street address to resolve that question.

Other therapy categories use the phrases “investigational neuropeptide protocols” and “research applications.” Those descriptions leave questions about the intended use of those particular offerings. They do not by themselves establish a regulatory finding about Lumora or identify the formulation used for weight management. Ask about the specific treatment you are considering rather than transfer a claim from one catalog category to another.

How much confidence to place in this review

The August 2026 FDA warning-letter search recorded no matching letter for the brand and identified entity. That is a dated search result, not regulatory clearance or a guarantee about current practice. The later October check concerned public prices and costs; it did not repeat that regulatory search or establish what happens after the first intake screen.

For now, the practical decision is whether Lumora will give you a clear product description and itemized quote before commitment. Required labs, visit charges, follow-up arrangements and renewal terms belong beside the medication cost. If those answers are not available, I would keep comparing rather than treat the missing price as either a bargain or proof that the care is unsuitable.